Vir Biotechnology, Inc. VIR Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s operating lease liabilities?
- Vir Biotechnology, Inc. (VIR) reported operating lease liabilities of -$2.27M in Q1 2026.
- How has Vir Biotechnology, Inc.'s operating lease liabilities changed year-over-year?
- Vir Biotechnology, Inc.'s operating lease liabilities decreased by 26.6% year-over-year, from -$1.8M to -$2.27M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s operating lease liabilities has grown at a 92.6% compound annual growth rate (CAGR), from -$535K to -$7.37M.